• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮乙醇注射治疗甲状腺结节:一项对比研究。

Percutaneous injection of ethanol for thyroid nodule treatment: a comparative study.

机构信息

Faculdade de Medicina da Bahia (UFBA), Hospital São Rafael (HSR), Salvador, BA, Brasil,

Faculdade de Medicina da Bahia (UFBA), Salvador, BA, Brasil.

出版信息

Arch Endocrinol Metab. 2021 Nov 3;65(3):322-327. doi: 10.20945/2359-3997000000363. Epub 2021 Apr 29.

DOI:10.20945/2359-3997000000363
PMID:33939906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10065334/
Abstract

OBJECTIVE

Percutaneous ethanol injection (PEI) is an alternative to surgery for the treatment of thyroid nodules (TNs). However, size reductions of treated (TTNs) and untreated TN (UTNs) have not been compared. Volumetric reductions in TTNs with PEI were evaluated by comparing TTNs and UTNs in the same patient, and independent variables predicting good post-PEI outcomes were analyzed.

METHODS

Overall, 282 patients with multinodular goiters were selected. Two nodules located in different lobes were compared for common disease behaviors. Overall, 150 nodules were selected from 75 patients (6 M: 69 F) with a mean age of 50.1 ± 17.4 years. This prospective nonrandomized intervention study prioritized treating TNs of greater volume or single hyperfunctioning TNs. A single observer experienced in PEI and an ultrasound specialist performed the interventions.

RESULTS

TTNs (mean volume: 14.8 ± 16.2 mL) were reduced by 72.6 ± 27.3% of their initial volume, while UTNs increased by a mean of 365.7 ± 1.403.8% (p < 0.00001). The patients underwent a mean of 4.0 ± 3.1 outpatient PEI sessions without relevant complications. Logistic regression analysis showed that the magnitude of the PEI induced reduction was associated with the number of treatment sessions (p = 0.03, CI [1.1-38.2]) and not with ultrasonographic characteristics of the nodules. Each PEI session increased the rate of TN reduction by a factor of 6.7.

CONCLUSION

PEI is a well-tolerated outpatient procedure that effectively reduces the volume of TNs and is noticeably superior to conservative treatment for all ultrasonographic classifications.

摘要

目的

经皮乙醇注射(PEI)是治疗甲状腺结节(TN)的手术替代方法。然而,治疗后的结节(TTN)和未治疗的 TN(UTN)的大小减少尚未进行比较。通过比较同一患者的 TTN 和 UTN,评估了 PEI 治疗 TTN 的体积减少,并分析了预测 PEI 后良好结局的独立变量。

方法

总共选择了 282 例多结节性甲状腺肿患者。比较了位于不同叶的两个结节以评估其共同的疾病行为。总共从 75 例(6 例男性:69 例女性)患者中选择了 150 个结节,这些患者的平均年龄为 50.1 ± 17.4 岁。这项前瞻性非随机干预研究优先治疗体积较大的 TN 或单发功能亢进的 TN。一位有经验的 PEI 单名观察者和一位超声专家进行了干预。

结果

TTN(平均体积:14.8 ± 16.2 mL)的初始体积减少了 72.6 ± 27.3%,而 UTN 的平均增加了 365.7 ± 1.403.8%(p < 0.00001)。患者平均接受了 4.0 ± 3.1 次门诊 PEI 治疗,没有出现相关并发症。逻辑回归分析显示,PEI 诱导的减少幅度与治疗次数有关(p = 0.03,CI [1.1-38.2]),而与结节的超声特征无关。每次 PEI 治疗可使 TN 减少的速度提高 6.7 倍。

结论

PEI 是一种耐受良好的门诊程序,可有效降低 TN 的体积,并且在所有超声分类中明显优于保守治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/1864667bc354/2359-4292-aem-65-03-0322-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/859143594dee/2359-4292-aem-65-03-0322-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/98b974e984e8/2359-4292-aem-65-03-0322-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/1864667bc354/2359-4292-aem-65-03-0322-gf03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/859143594dee/2359-4292-aem-65-03-0322-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/98b974e984e8/2359-4292-aem-65-03-0322-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fad/10065334/1864667bc354/2359-4292-aem-65-03-0322-gf03.jpg

相似文献

1
Percutaneous injection of ethanol for thyroid nodule treatment: a comparative study.经皮乙醇注射治疗甲状腺结节:一项对比研究。
Arch Endocrinol Metab. 2021 Nov 3;65(3):322-327. doi: 10.20945/2359-3997000000363. Epub 2021 Apr 29.
2
Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients.经皮乙醇注射治疗高功能甲状腺结节的五年随访:117例患者的研究
Clin Endocrinol (Oxf). 1997 Jan;46(1):9-15. doi: 10.1046/j.1365-2265.1997.d01-1752.x.
3
Levothyroxine or minimally invasive therapies for benign thyroid nodules.左甲状腺素或用于良性甲状腺结节的微创治疗
Cochrane Database Syst Rev. 2014 Jun 18;2014(6):CD004098. doi: 10.1002/14651858.CD004098.pub2.
4
Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients.经皮乙醇注射治疗功能亢进性甲状腺结节:125例患者的长期随访
AJR Am J Roentgenol. 2008 Mar;190(3):800-8. doi: 10.2214/AJR.07.2668.
5
Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.放射性碘与经皮乙醇注射治疗巨大毒性甲状腺结节的长期研究
Thyroid. 2000 Nov;10(11):985-9. doi: 10.1089/thy.2000.10.985.
6
Treatment of hyperfunctioning thyroid nodules with percutaneous ethanol injection: Eight years' experience.经皮乙醇注射治疗高功能甲状腺结节:八年经验
Exp Clin Endocrinol Diabetes. 1998;106 Suppl 4:S54-8. doi: 10.1055/s-0029-1212058.
7
Percutaneous ethanol injection of autonomous thyroid nodules with a volume larger than 40 ml: three years of follow-up.经皮乙醇注射治疗体积大于40毫升的自主性甲状腺结节:三年随访
Clin Radiol. 2001 Nov;56(11):895-901. doi: 10.1053/crad.2001.0787.
8
Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules.经皮乙醇注射联合放射性碘与单纯放射性碘治疗大型毒性甲状腺结节的比较
J Nucl Med. 2003 Feb;44(2):207-10.
9
Percutaneous ethanol injection of large autonomous hyperfunctioning thyroid nodules.经皮乙醇注射治疗大型自主性高功能甲状腺结节
Radiology. 2000 Jan;214(1):143-8. doi: 10.1148/radiology.214.1.r00ja13143.
10
Evaluation of percutaneous ethanol injections in benign thyroid nodules.经皮乙醇注射治疗良性甲状腺结节的评估
Arq Bras Endocrinol Metabol. 2014 Dec;58(9):912-7. doi: 10.1590/0004-2730000003444.

本文引用的文献

1
VASCULARITY-TARGETED PERCUTANEOUS ETHANOL INJECTION OF TOXIC THYROID ADENOMAS: OUTCOMES OF A FEASIBILITY STUDY PERFORMED IN THE USA.美国进行的一项可行性研究:血管靶向性经皮乙醇注射治疗毒性甲状腺腺瘤:结果。
Endocr Pract. 2020 Jan;26(1):22-29. doi: 10.4158/EP-2019-0329. Epub 2019 Aug 28.
2
Predictors of Poor Bone Microarchitecture Assessed by Trabecular Bone Score in Postsurgical Hypoparathyroidism.术后甲状旁腺功能减退症患者骨小梁骨评分评估的骨微结构不良的预测因素。
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5795-5803. doi: 10.1210/jc.2019-00698.
3
Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology.
甲状腺结节乙醇消融治疗:韩国甲状腺放射学会 2018 年共识声明。
Korean J Radiol. 2019 Apr;20(4):609-620. doi: 10.3348/kjr.2018.0696.
4
The Diagnosis and Management of Thyroid Nodules: A Review.甲状腺结节的诊断与处理:综述
JAMA. 2018 Mar 6;319(9):914-924. doi: 10.1001/jama.2018.0898.
5
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.低危甲状腺微小乳头状癌:主动监测试验的回顾。
Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16.
6
Percutaneous ethanol injection versus conservative treatment for benign cystic and mixed thyroid nodules.经皮乙醇注射与保守治疗良性囊性及混合性甲状腺结节的比较
Arch Endocrinol Metab. 2016 Feb 23;60(3):211-6. doi: 10.1590/2359-3997000000120.
7
Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years.经皮乙醇硬化疗法治疗孕妇有症状结节有效且安全:13例患者平均随访6.8年的研究
Int J Endocrinol. 2015;2015:765950. doi: 10.1155/2015/765950. Epub 2015 Nov 30.
8
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
9
The natural history of benign thyroid nodules.良性甲状腺结节的自然病程。
JAMA. 2015 Mar 3;313(9):926-35. doi: 10.1001/jama.2015.0956.
10
Evaluation of percutaneous ethanol injections in benign thyroid nodules.经皮乙醇注射治疗良性甲状腺结节的评估
Arq Bras Endocrinol Metabol. 2014 Dec;58(9):912-7. doi: 10.1590/0004-2730000003444.